feed,title,long_url,short_url
SeekingAlpha,Hempacco scales 58% as revenue up 486% Y/Y for H1 2022,https://seekingalpha.com/news/3890699,
SeekingAlpha,Galectin rises as FDA approves to begin human trial of combination immunotherapy in head and neck cancer,https://seekingalpha.com/news/3890698,
SeekingAlpha,"SENS, UMC and SLS among pre market gainers",https://seekingalpha.com/news/3890697,
